Aegerion Pharmaceuticals Inc. agreed to plead guilty in the United States District Court for the District of Massachusetts to two misdemeanor counts of violating the Federal Food, Drug, and Cosmetic Act (FD&C Act) involving the introduction of misbranded Juxtapid (lomitapide) into interstate commerce.
from Food and Drug Administration--Press Releases http://ift.tt/2xYc9yL
via IFTTT
No comments:
Post a Comment